<div id="report-related">


<h2>Additional Impact</h2>

<h3>Congressional Testimony</h3>

<ul>

<li><a class="fancybox iframe" title="" href="https://www.youtube.com/embed/U2amEojt2_0"><img src="/newsroom/video/2015/amaxwell-0315.jpg" alt="A still from the video" /></a></li>
</ul>

<p><strong>Examining the 340B Drug Pricing Program.</strong> Testimony of Ann Maxwell, Assistant Inspector General of OIG's Office of Evaluation and Inspections. (March 2015) <a class="fancybox iframe" title="" href="https://www.youtube.com/embed/U2amEojt2_0">Watch the above video</a> or <a href="https://oig.hhs.gov/testimony/docs/2015/maxwell-032415.pdf">read the testimony</a>.</p>

<p><strong>Pricing of Separately Billable End Stage Renal Disease Drugs.</strong>  Testimony of Robert A. Vito, Regional Inspector General for OIG's Office of Evaluation and Inspections. (July 2007) <a href="https://oig.hhs.gov/testimony/docs/2007/ESRD Written Testimony Jun 25 2007.pdf">Read the testimony</a></p>

 
<p><strong>Medicare Part B Prescription Drug Reimbursements.</strong> Testimony of Robert A. Vito, Regional Inspector General for OIG's Office of Evaluation and Inspections. (July 2006)  <a href="https://oig.hhs.gov/testimony/docs/2006/60713fin.pdf">Read the testimony</a></p>


<h3>Enforcement</h3>

<p>Pharmaceutical Manufacturers Pay $421.2 Million to Settle False Claims Act Cases (December 2010; U.S. Department of Justice) <a href="https://www.justice.gov/opa/pr/pharmaceutical-manufacturers-pay-4212-million-settle-false-claims-act-cases">Read the News Release</a></p>

</div> 
